Found: 8
Select item for more details and to access through your institution.
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03600-6
- By:
- Publication type:
- Article
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR- collagen interaction.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.62927
- By:
- Publication type:
- Article
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.92870
- By:
- Publication type:
- Article
Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, p. 1, doi. 10.1186/s12967-024-05199-3
- By:
- Publication type:
- Article
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.733561
- By:
- Publication type:
- Article
Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01793
- By:
- Publication type:
- Article
Signaling by the inhibitory receptor CD200R is rewired by type I interferon.
- Published in:
- Science Signaling, 2021, v. 14, n. 704, p. 1, doi. 10.1126/scisignal.abb4324
- By:
- Publication type:
- Article
CD200R1L is a functional evolutionary conserved activating receptor in human neutrophils.
- Published in:
- Journal of Leukocyte Biology, 2022, v. 111, n. 2, p. 367, doi. 10.1002/JLB.2A0520-334R
- By:
- Publication type:
- Article